ADHD
Conditions
Keywords
ADHD, Neurofeedback, Self-Management, Parental Psychoeducation, Social Support
Brief summary
Neurofeedback has proved to be effective in treating Attention deficit hyperactivity disorder (ADHD) in experimental settings. This study investigates whether neurofeedback can be used as a therapeutic intervention in regular outpatient care. The investigators compare high frequent neurofeedback with high frequent self-management therapy and suppose that both result in comparable effects.
Sponsors
Philipps University Marburg
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
7 Years to 11 Years
Healthy volunteers
No
Inclusion criteria
* children with ADHD aged 7 to 11 * full command of the German language.
Exclusion criteria
* IQ below 80 Children with symptoms of: * inattention, * hyperactivity or * impulsivity due to other medical reasons such as: * hyperthyreosis, * autism, * epilepsy, * brain disorders and * any genetic or medical disorder associated with externalizing behavior that mimics ADHD.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Core ADHD symptoms (inattention/hyperactivity/impulsivity) objectively assessed with the computer based Qb-Test (go-no-go-task with infrared camera) | Pre-Post-Change-Design; change for core symptoms from baseline to after 12 weeks, 6 and 12 months | Children perform the Qb-Test: * T1 baseline diagnostic before therapy, 1 week * T2 post assessment after 36 therapy sessions, expected average of 12 weeks * T3 catamnestic measurement 6 months after T2 * T4 catamnestic measurement 12 months after T2 |
| Conners Psychopathology Scores | Pre-Post-Change-Design; change from baseline to psychopathology scores after 12 weeks, 6 and 12 months | Conners parents & teacher rating scales: * T1 baseline diagnostic before therapy, 1 week * T2 post assessment after 36 therapy sessions, expected average of 12 weeks * T3 catamnestic measurement 6 months after T2 * T4 catamnestic measurement 12 months after T2 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Perceived Criticism | Pre-Post-Change-Design; change from baseline to perceived criticism scores after 12 weeks, 6 and 12 months | Assessment of children's perceived criticism: * T1 baseline diagnostic before therapy, 1 week * T2 post assessment after 36 therapy sessions, expected average of 12 weeks * T3 catamnestic measurement 6 months after T2 * T4 catamnestic measurement 12 months after T2 |
| Parental Stress (ESF) | Pre-Post-Change-Design; change from baseline to parental stress scores after 12 weeks, 6 and 12 months | Parent Stress Questionnaire: * T1 baseline diagnostic before therapy, 1 week * T2 post assessment after 36 therapy sessions, expected average of 12 weeks * T3 catamnestic measurement 6 months after T2 * T4 catamnestic measurement 12 months after T2 |
| Social Support | Pre-Post-Change-Design; change from baseline to social support scores after 12 weeks, 6 and 12 months | Children's social support scale: * T1 baseline diagnostic before therapy, 1 week * T2 post assessment after 36 therapy sessions, expected average of 12 weeks * T3 catamnestic measurement 6 months after T2 * T4 catamnestic measurement 12 months after T2 |
| Blood/saliva samples for possible genetic correlates of therapy response | End of therapy after 36 sessions | Either saliva sampling or blood samples for genotyping of ADHD candidate genes to establish possible correlates of therapy response |
| Cortisol | Pre-Post-Change-Design; change from baseline to cortisol levels after 12 weeks, 6 and 12 month | Assessed with hair-samples: * T1 baseline diagnostic before therapy, 1 week * T2 post assessment after 36 therapy sessions, expected average of 12 weeks * T3 catamnestic measurement 6 months after T2 * T4 catamnestic measurement 12 months after T2 |
| Self-Concept | Pre-Post-Change-Design; change from baseline to self-concept scores after 12 weeks, 6 and 12 months | Children's self-concept interview: * T1 baseline diagnostic before therapy, 1 week * T2 post assessment after 36 therapy sessions, expected average of 12 weeks * T3 catamnestic measurement 6 months after T2 * T4 catamnestic measurement 12 months after T2 |
Countries
Germany
Contacts
Primary ContactHanna Christiansen, PhD
Backup ContactWinfried Rief, PhD
Outcome results
None listed